Previous 10 | Next 10 |
Combined Company Pro Forma 2019 Net Product Sales of Approximately $128 Million 1 Expects to Capture Significant Operating and Product Portfolio Synergies Upwards of $40 Million, Accelerating Revenue Growth and Creating Shareholder Value Arthur Higgins to Become the Non-Executive...
WAYNE, Penn. , March 13, 2020 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial stage life sciences company, today announced that its year end 2019 financial results will be released on March 27, 2020 . Following the announcement, Zyla's management will host a live ...
Zyla Life Sciences (ZCOR) Q3 2019 Earnings Conference Call November 14, 2019 4:30 P.M. ET Company Participants Blair Clark-Schoeb - Senior Vice President, Communications Todd Smith - President and Chief Executive Officer Jesse Neri - Vice President, Finance Conference Call Pa...
Zyla Life Sciences ( OTCQX:ZCOR ): Q3 net loss of $10.3M Revenue of $22.39M (+174.7% Y/Y) Press Release More news on: Zyla Life Sciences, Earnings news and commentary, Healthcare stocks news, ,
WAYNE, Pa. , Nov. 14, 2019 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla" or the "Company"), a commercial-stage life sciences company, today reported financial results for the third quarter ended September 30, 2019 , including net sales from commercial products: ...
WAYNE, Pa. , Oct. 31, 2019 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company focused on marketing treatments for different types of pain and inflammation, today announced that its third quarter 2019 financial results will be released ...
WAYNE, Pa. , Oct. 23, 2019 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company, today announced that Robert Radie , has resigned as president, chief executive officer and director of the Company to pursue other opportunities. Mr. Radie...
WAYNE, Pa. , Sept. 3, 2019 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial-stage life sciences company, announced that Bob Radie , president and chief executive officer of Zyla, will give a corporate presentation and participate in a panel at the 2019 Disrupt...
Zyla Life Sciences (ZCOR) Q2 2019 Earnings Conference Call August 13, 2019 16:30 ET Company Participants Blair Clark-Schoeb - SVP, Communications Bob Radie - President & CEO Jesse Neri - VP, Finance Conference Call Participants Presentation Operator Good afterno...
Zyla Life Sciences ( OTCQX:ZCOR ): Q2 Net loss of $19.64M. More news on: Zyla Life Sciences, Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
WAYNE, Penn. , May 15, 2020 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla" or the "Company"), a commercial-stage life sciences company, today reported financial results for the first quarter ended March 31, 2020 , including net sales from commercial products: SPR...
WAYNE, Pa. , May 1, 2020 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla"), a commercial stage life sciences company, today announced that its 2020 first quarter financial results will be released on May 15, 2020 . Following the announcement, Zyla's management will host a li...
Merger with Zyla Life Sciences Expected to Close Shortly After the 2020 Annual Meeting Assertio Reaffirms its Ability to Achieve Upwards of $40 Million in Synergies Will Report First Quarter 2020 Financial Results on Monday, May 11, 2020 Prior to the Open of Markets LAKE ...